DBD-CAP was shown to affect also the proteolytic potential of tumor cells since it significantly down-regulated the expression of MMP-1, MT1-MMP and uPA in the metastatic ER- breast cancer cells (Figures 10B–D). The gene discussed is MMP1; the disease is neoplasm.